atorvastatin has been researched along with palmitic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Koszalka, P; Kutryb-Zajac, B; Slominska, EM; Smolenski, RT | 1 |
| Bian, Z; Chen, X; Gu, Y; Hu, R; Li, L; Liu, N; Ma, W; Wu, H; Yang, D; Zheng, P | 1 |
| Cho, HC; Choi, SH; Golfetto Miskiewicz, IC; Lee, J; Lee, JI; Lee, Y; Lee, YK | 1 |
3 other study(ies) available for atorvastatin and palmitic acid
| Article | Year |
|---|---|
The effects of pro- and anti-atherosclerotic factors on intracellular nucleotide concentration in murine endothelial cells.
Topics: Adenosine Triphosphate; Animals; Atherosclerosis; Atorvastatin; Blood Vessels; Cell Line; Cytokines; Docosahexaenoic Acids; Endothelial Cells; Fatty Acids, Unsaturated; Kaempferols; Linoleic Acid; Mice; NAD; Nucleotides; Palmitic Acid; Pyridines | 2018 |
Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway.
Topics: Animals; Atorvastatin; Cardiomegaly; Carnitine O-Palmitoyltransferase; Fatty Acids; Mice; Mitochondria; Myocytes, Cardiac; Palmitic Acid; Rats; STAT3 Transcription Factor | 2023 |
Effect of atorvastatin on lipoxygenase pathway-related gene expression in an in vitro model of lipid accumulation in hepatocytes.
Topics: Atorvastatin; Gene Expression; Hepatocytes; Humans; Inflammation; Lipoxygenase; Lipoxygenases; Palmitic Acid; Phospholipases A2, Cytosolic | 2023 |